Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 6/20 | 0.32 |
| ▸ | PDE4A | P27815 | 5/20 | 0.32 |
| ▸ | PDE4C | Q08493 | 5/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 5/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6867953 | 1.00 | PDE4B (0.32) | PDE4BPDE4APDE4CPDE4DADORA2A | |
| SCHEMBL6867958 | 1.00 | PDE4B (0.32) | PDE4BPDE4APDE4CPDE4DADORA2A | |
| SCHEMBL6871721 | 0.88 | PDE4B (0.46) | PDE4BPDE4APDE4CPDE4DMAPT | |
| SCHEMBL6871720 | 0.88 | PDE4B (0.46) | PDE4BPDE4APDE4CPDE4DMAPT | |
| SCHEMBL6871724 | 0.88 | PDE4B (0.46) | PDE4BPDE4APDE4CPDE4DMAPT | |
| SCHEMBL6870967 | 0.88 | PDE4B (0.40) | PDE4BPDE4APDE4CPDE4DMAPT | |
| SCHEMBL6870961 | 0.88 | PDE4B (0.40) | PDE4BPDE4APDE4CPDE4DMAPT | |
| SCHEMBL6870965 | 0.88 | PDE4B (0.40) | PDE4BPDE4APDE4CPDE4DMAPT | |
| SCHEMBL6869154 | 0.87 | PDE4B (0.38) | PDE4BPDE4APDE4CPDE4DMAPT | |
| SCHEMBL6869160 | 0.87 | PDE4B (0.38) | PDE4BPDE4APDE4CPDE4DMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1095040-B1 | NEW BENZOXAZOLES WITH PDE-INHIBITING ACTIVITY | ALTANA PHARMA AG (DE) | 2004-03-31 | — | — | EP | disclosed |
| US-6376485-B1 | SELECTIVE PHOSPHODIESTERASE INHIBITORS FOR TREATING ASTHMA, BRONCHITIS, AND EMPHYSEMA; HIGH BIOAVAILABILITY AND LOW TOXICITY | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 2002-04-23 | — | — | US | disclosed |